SCHEMBL23419600

SCHEMBL23419600

CC(C)c1ccc(CCN)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 3/20 0.42
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
HTR1D P28221 1/20 0.38
HRH4 Q9H3N8 2/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
MTOR P42345 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
DHFR P00374 1/20 0.34
PPARG P37231 1/20 0.34
IDO1 P14902 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
KMT2A Q03164 1/20 0.33
STK17B O94768 1/20 0.33
STK17A Q9UEE5 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20802511 0.85 ESR1 (0.39) ESR1ESR2DHFRPPARGMEN1
SCHEMBL4369960 0.84 ESR1 (0.41) ESR1ESR2DHFRIDO1MEN1
SCHEMBL12243808 0.82 ESR1 (0.40) ESR1ESR2TSHRHRH3DHFR
SCHEMBL20332457 0.81 ESR1 (0.42) ESR1ESR2DHFRPPARGMEN1
SCHEMBL828068 0.79 GABRP (0.40) ESR1ESR2TSHRTDP1IDO1
SCHEMBL20332789 0.78 L3MBTL1 (0.39) ESR1ESR2PPARGMEN1LMNA
SCHEMBL19107508 0.78 ESR1 (0.37) ESR1ESR2DHFRPPARGMEN1
SCHEMBL2604908 0.78 ESR1 (0.42) ESR1ESR2HRH3IDO1MEN1
SCHEMBL23206735 0.77 KCNH2 (0.46) ESR1ESR2TDP1MEN1KMT2A
SCHEMBL24067622 0.77 MEN1 (0.37) ESR1ESR2PPARGMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021102332-A1 TGFBETAR2 INHIBITOR-LRRC15 ANTIBODY CONJUGATES AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2021-05-27 WO disclosed